Skip to content

Welcome to Discover Pharma! Today is : November 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics,Therapeutic Areas

    Xeltis poised for commercialization following positive EU pivotal trial results

    Xeltis has announced successful clinical data from its aXess EU [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    CPHI Frankfurt Pharma Awards 2025 finalists unveiled, spotlighting innovation, sustainability and industry leadership

    From synthetic biology to patient access, AI-powered formulation to sustainable [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    N4 Pharma and SRI demonstrate targeted Nuvec delivery to lung cancer cells

    N4 Pharma has reported new data from its collaboration with [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Acella Pharmaceuticals reports positive Phase 2 results for North Star desiccated thyroid extract

    Acella Pharmaceuticals and Neuvosyn Laboratories have reported positive topline results [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Persista Bio wins NIH funding to advance O2Line cell therapy

    Persista Bio has been awarded two grants from the US [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gene therapy AMT-130 slows Huntington’s disease progression in early trial

    A gene therapy developed by uniQure appears to slow progression [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    CureDuchenne announces Fuerza 2025 conference in Mexico City on Duchenne and Becker muscular dystrophy

    CureDuchenne will host CureDuchenne Fuerza 2025, a one-day educational and [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Poolbeg secures free supply of bispecific antibody for POLB 001 trial at The Christie

    Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    May 5, 2026
Previous525354Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Adneuris licenses cebranopadol to Maruishi in $35M Japan and South Korea deal
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • BlueWind wins FDA clearance for longer-lasting Revi implant for urinary incontinence
    Categories: Clinical & Regulatory, Medical devices, Therapeutic Areas
  • AI virtual screening tool boosts hit rate 100-fold on challenging drug targets
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top